Antibody therapy reverses biological signatures of COVID-19 progression

Maher, MC; Soriaga, LB; Gupta, A; Chen, YP; di Iulio, J; Ledoux, S; Smithey, MJ; Cathcart, AL; McKusick, K; Sun, DV; Aldinger, M; Alexander, E; Purcell, L; Ding, X; Peppercorn, A; Austin, D; Mogalian, E; Yeh, WW; Shapiro, AE; Corti, D; Virgin, HW; Pang, PS; Telenti, A

Maher, MC; Telenti, A (通讯作者),Vir Biotechnol, San Francisco, CA 94158 USA.

CELL REPORTS MEDICINE, 2022; 3 (8):

Abstract

Understanding who is at risk of progression to severe coronavirus disease 2019 (COVID-19) is key to clinical decision making and effective treatment. ......

Full Text Link